Skip to main content

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2023

Institutional positions in Esperion Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
123
0 vs. Q2 2023
Shares held
77.3M
+2.90M (+3.9%) vs. Q2 2023
Total value
$75.9M
−$27.7M (−26.7%) vs. Q2 2023
New holders
21
36 more added
Sold out
21
31 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ESPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 123 institutions
Q1 2021: 156 institutionsQ2 2021: 142 institutionsQ3 2021: 139 institutionsQ4 2021: 133 institutionsQ1 2022: 132 institutionsQ2 2022: 137 institutionsQ3 2022: 148 institutionsQ4 2022: 164 institutionsQ1 2023: 165 institutionsQ2 2023: 124 institutionsQ3 2023: 123 institutionsQ4 2023: 132 institutionsQ1 2024: 152 institutionsQ2 2024: 176 institutionsQ3 2024: 184 institutionsQ4 2024: 190 institutionsQ1 2025: 187 institutionsQ2 2025: 164 institutionsQ3 2025: 189 institutionsQ4 2025: 201 institutionsQ1 2026: 207 institutionsQ2 2026: 191 institutions
Value heldQ3 2023: $75.9M
Q1 2021: $805.3MQ2 2021: $599.4MQ3 2021: $299.4MQ4 2021: $268.0MQ1 2022: $241.2MQ2 2022: $352.1MQ3 2022: $425.5MQ4 2022: $457.6MQ1 2023: $129.1MQ2 2023: $103.6MQ3 2023: $75.9MQ4 2023: $215.3MQ1 2024: $336.2MQ2 2024: $304.2MQ3 2024: $214.3MQ4 2024: $277.9MQ1 2025: $171.5MQ2 2025: $96.6MQ3 2025: $286.1MQ4 2025: $559.6MQ1 2026: $479.3MQ2 2026: $646.8M
Institutions holding ESPR and their total value by quarter
QuarterHoldersValue
Q2 2026191$646.8M
Q1 2026207$479.3M
Q4 2025201$559.6M
Q3 2025189$286.1M
Q2 2025164$96.6M
Q1 2025187$171.5M
Q4 2024190$277.9M
Q3 2024184$214.3M
Q2 2024176$304.2M
Q1 2024152$336.2M
Q4 2023132$215.3M
Q3 2023123$75.9M
Q2 2023124$103.6M
Q1 2023165$129.1M
Q4 2022164$457.6M
Q3 2022148$425.5M
Q2 2022137$352.1M
Q1 2022132$241.2M
Q4 2021133$268.0M
Q3 2021139$299.4M
Q2 2021142$599.4M
Q1 2021156$805.3M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Esperion Therapeutics, Inc.; share changes are against Q2 2023.

Institutions holding ESPR in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
PSI Advisors, LLC6,500$6.37K0.00%00.0%Unchanged
Quantbot Technologies LP6,122$6.00K0.00%−4,119−40.2%Reduced
Rhumbline Advisers3,784$3.71K0.00%−3,353−47.0%Reduced
Wells Fargo & Company3,255$3.19K0.00%+103+3.3%Added
China Universal Asset Management Co., Ltd.2,748$2.69K0.00%+1,507+121.4%Added
Laurel Wealth Advisors LLC2,500$2.45K0.00%00.0%Unchanged
DHJJ Financial Advisors, Ltd.1,500$1.47K0.00%+1,500New
US Bancorp1,083$1.06K0.00%00.0%Unchanged
CWM, LLC850$1.00K0.00%00.0%Unchanged
GWM Advisors LLC600$5880.00%00.0%Unchanged
Cary Street Partner Investment Advisory LLC550$5390.00%00.0%Unchanged
Parkside Financial Bank & Trust400$3920.00%00.0%Unchanged
South State Corp.314$3080.00%00.0%Unchanged
Barrett & Company, Inc.300$2940.00%00.0%Unchanged
Trust Co of Vermont300$2940.00%00.0%Unchanged
Cornerstone Planning Group LLC123$1210.00%00.0%Unchanged
Sunbelt Securities, Inc.100$980.00%00.0%Unchanged
Creative Planning100$980.00%+100New
TD Waterhouse Canada Inc.60$800.00%00.0%Unchanged
Jefferies Financial Group Inc.65$640.00%−112,127−99.9%Reduced
Elequin Capital LP10$100.00%−300−96.8%Reduced
Harbour Investments, Inc.7$70.00%00.0%Unchanged
Benjamin F. Edwards & Company, Inc.325$00.00%00.0%Unchanged
Armistice Capital, LLC0$00.00%−9,193,000−100.0%Sold out
Braidwell LP0$00.00%−895,949−100.0%Sold out
Public Employees Retirement System of Ohio0$00.00%−252,516−100.0%Sold out
Pentwater Capital Management LP0$00.00%−181,290−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−111,482−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−109,072−100.0%Sold out
Ergoteles LLC0$00.00%−58,600−100.0%Sold out
Old Mission Capital LLC0$00.00%−52,029−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−42,802−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−41,809−100.0%Sold out
Laurion Capital Management LP0$00.00%−35,146−100.0%Sold out
BlueCrest Capital Management Ltd0$00.00%−25,426−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−16,039−100.0%Sold out
Neuberger Berman Group LLC0$00.00%−15,899−100.0%Sold out
LMR Partners LLP0$00.00%−12,400−100.0%Sold out
Captrust Financial Advisors0$00.00%−10,102−100.0%Sold out
O'Dell Group, LLC0$00.00%−4,500−100.0%Sold out
Headlands Technologies LLC0$00.00%−2,110−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−1,000−100.0%Sold out
New York State Common Retirement Fund0$00.00%−628−100.0%Sold out
IFP Advisors, Inc0$00.00%−44−100.0%Sold out
Kistler-Tiffany Companies, LLC––––Not filed